tirzepatide heart failure Semaglutide and in Patients With With Preserved Ejection Fraction In patients with cardiometabolic HFpEF, semaglutide and tirzepatide showed more than 40% risk reduction for the composite of hospitalization for Weight-loss drug tirzepatide may lower

The FDA requires generic drugs to have the same active ingredient, strength, dosage form, and route of administration as the brand-name version

Unsupervised clustering studies suggest identifiable endotypes with distinct reproductive and metabolic characteristics, such as the differentiation between reproductive-dominant and metabolic-dominant subtypes (171, 172)

Studies document that semaglutide users achieve HbA1c reductions of 12 percentage points, a meaningful shift in long-term blood sugar control

There is no one-size-fits-all approach to weight management, and your unique medical history and goals should guide your treatment